DGAP-News: SYGNIS AG: SYGNIS AG successfully completes Rights Offering
(firmenpresse) - DGAP-News: SYGNIS AG / Key word(s): Capital Increase
SYGNIS AG: SYGNIS AG successfully completes Rights Offering
28.10.2013 / 09:09
---------------------------------------------------------------------
Press Release
SYGNIS AG successfully completes Rights Offering
and Private Placement
Heidelberg, Germany, October 28, 2013 - SYGNIS AG (Frankfurt: LIO1; ISIN:
DE000A1RFM03, Prime Standard) today announced that the Company has
successfully completed its rights offering. The subscription price was EUR
2.65 per share. New shares that were not subscribed in the course of the
rights offering by existing shareholders were offered to selected German
and international institutional investors in a private placement at a
purchase price equivalent to the subscription price. In the transaction
1,019,309 new shares against cash were subscribed.
The Management Board, with the approval of the Supervisory Board, has
resolved to increase the Company's share capital from EUR 9,364,258.00 to
EUR 10,383,567.00 by issuing 1,019,309 new shares. The offering utilizes
existing authorized capital created by resolution at the Annual General
Meeting on August 28, 2013. The new shares carry full dividend rights as of
January 1, 2013.
'We welcome our new shareholders and are very thankful for their trust in
the new business direction of SYGNIS,' stated Pilar de la Huerta, CEO and
CFO of SYGNIS AG. 'SYGNIS is a key player in the fast growing market of DNA
amplification and sequencing. With the first commercial agreement around
SYGNIS' core technology QualiPhi(R) with QIAGEN, the world leading provider
of sample and assay technologies and a full pipeline with potential
blockbuster products for next generation sequencing applications, SYGNIS is
best positioned to benefit from the high growth rates we are seeing in
gene-based personalized healthcare, molecular diagnostics and epigenetics.
The transaction is in our view in the best interest of the Company and its
shareholders as it provides the Company with the financial flexibility
needed to further execute on its business plans and closes the gap to
break-even expected in 2014.'
SYGNIS plans to use the gross proceeds of EUR 2.7 million to finance its
operating business and further growth.
For further information please contact:
SYGNIS AGAbout SYGNIS AG: www.sygnis.com
Pilar de la Huerta
CEO/CFO
Tel: +34-918063089
Email: pdelahuerta(at)sygnis.es
After the merger in 2012 between X-Pol Biotech, specialising in DNA
amplification and sequencing, and SYGNIS AG, listed in the German Stock
Exchange (Prime Standard segment, Tick: LIO1; ISIN: DE000A1RFM03), SYGNIS'
new mission is to develop and distribute technologies and products from
X-Pol, which has a commercial product in the DNA amplification segment,
QualiPhi(R) and is currently developing other products in the field of Next
Generation Sequencing.
### Disclaimer
This publication is intended for information only and constitutes neither
an offer to sell nor an invitation to buy securities. Some statements
included in this press release, relating neither to proven financial
results nor other historical data, should be viewed as forward-looking,
i.e. not definite. Such statements are mainly predictions of future
results, trends, plans or goals. These statements should not be considered
to be total guarantees since given their very nature they are subject to
known and unknown risks and imponderability and can be affected by other
factors as a consequence of which the actual results, plans and goals of
SYGNIS AG may deviate greatly from the established conclusions or implied
predictions contained in such statements. SYGNIS does not undertake to
publicly update or revise these statements in the light of new information
or future results or for any other reason.###
End of Corporate News
---------------------------------------------------------------------
28.10.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: SYGNIS AG
Im Neuenheimer Feld 515
69120 Heidelberg
Germany
Phone: 06221 454-6
Fax: 06221 454-700
E-mail: contact(at)sygnis.de
Internet: www.sygnis.de
ISIN: DE000A1RFM03
WKN: A1RFM0
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
236398 28.10.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 28.10.2013 - 09:09 Uhr
Sprache: Deutsch
News-ID 309674
Anzahl Zeichen: 5545
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 247 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: SYGNIS AG: SYGNIS AG successfully completes Rights Offering"
steht unter der journalistisch-redaktionellen Verantwortung von
SYGNIS AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
